BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26249360)

  • 21. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways.
    Fu J; Chen Y; Cao J; Luo T; Qian YW; Yang W; Ren YB; Su B; Cao GW; Yang Y; Yan YQ; Shen F; Wu MC; Feng GS; Wang HY
    Hepatology; 2011 Jan; 53(1):181-92. PubMed ID: 21254169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.
    Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.
    Liang B; Chen R; Wang T; Cao L; Liu Y; Yin F; Zhu M; Fan X; Liang Y; Zhang L; Guo Y; Zhao J
    Clin Cancer Res; 2013 Jun; 19(11):2905-16. PubMed ID: 23549880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC.
    Ding K; Fan L; Chen S; Wang Y; Yu H; Sun Y; Yu J; Wang L; Liu X; Liu Y
    Oncol Rep; 2015 Dec; 34(6):3297-303. PubMed ID: 26397192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
    Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules.
    Luo Q; Zhang Y; Wang N; Jin G; Jin H; Gu D; Tao X; Huo X; Ge T; Cong W; Wang C; Qin W
    Oncotarget; 2015 Mar; 6(9):6989-99. PubMed ID: 25749520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma.
    Wang H; Xu L; Zhu X; Wang P; Chi H; Meng Z
    Oncol Rep; 2014 Oct; 32(4):1465-72. PubMed ID: 25070581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Targetable Molecular Chaperone Hsp27 Confers Aggressiveness in Hepatocellular Carcinoma.
    Zhang Y; Tao X; Jin G; Jin H; Wang N; Hu F; Luo Q; Shu H; Zhao F; Yao M; Fang J; Cong W; Qin W; Wang C
    Theranostics; 2016; 6(4):558-70. PubMed ID: 26941848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma.
    Wu Y; Zhang Y; Qin X; Geng H; Zuo D; Zhao Q
    Pharmacol Res; 2020 Oct; 160():105195. PubMed ID: 32916254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma.
    Lu Y; Li X; Liu H; Xue J; Zeng Z; Dong X; Zhang T; Wu G; Yang K; Xu S
    Oncogene; 2021 Feb; 40(7):1269-1283. PubMed ID: 33420362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
    Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
    Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4.
    Shi WK; Shang QL; Zhao YF
    Oncol Rep; 2022 May; 47(5):. PubMed ID: 35293598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability.
    Liu Y; Zhang JB; Qin Y; Wang W; Wei L; Teng Y; Guo L; Zhang B; Lin Z; Liu J; Ren ZG; Ye QH; Xie Y
    Hepatology; 2013 Aug; 58(2):692-705. PubMed ID: 23505027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.
    Lin B; Zhou X; Lin S; Wang X; Zhang M; Cao B; Dong Y; Yang S; Wang JM; Guo M; Huang J
    J Mol Med (Berl); 2017 Nov; 95(11):1237-1249. PubMed ID: 28844099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling.
    Jiang F; Chen L; Yang YC; Wang XM; Wang RY; Li L; Wen W; Chang YX; Chen CY; Tang J; Liu GM; Huang WT; Xu L; Wang HY
    Cancer Res; 2015 Apr; 75(7):1470-81. PubMed ID: 25649767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression.
    Zhang W; Shi X; Chen R; Zhu Y; Peng S; Chang Y; Nian X; Xiao G; Fang Z; Li Y; Cao Z; Zhao L; Liu G; Sun Y; Ren S
    Mol Ther; 2020 Nov; 28(11):2473-2487. PubMed ID: 32592689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of IL-4R enhances proliferation and invasion of hepatocellular carcinoma cells.
    Guo C; Ouyang Y; Cai J; Xiong L; Chen Y; Zeng X; Liu A
    Int J Biol Markers; 2017 Oct; 32(4):e384-e390. PubMed ID: 28665449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
    Liu S; Zhang W; Liu K; Ji B; Wang G
    Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.